Form 4: Omega Healthcare Director Burke Whitman Receives Restricted Stock Grant as Compensation

Omega Healthcare Investors Inc. director Burke W. Whitman was granted 4,388 shares of common stock as compensation, increasing his beneficial ownership to 44,153 shares.

Summary

• Burke W. Whitman, a Director of Omega Healthcare Investors Inc. (OHI), acquired 4,388 shares of common stock.
• The transaction occurred on June 6, 2025, at a price of $37.6 per share.
• This acquisition represents director compensation granted via a Restricted Stock Grant Award Agreement.
• The granted shares will vest on the date of the Company's 2026 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis.
• Following this transaction, Mr. Whitman beneficially owns a total of 44,153 shares of Omega Healthcare Investors Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects a standard compensation practice for a director, aligning their interests with shareholders through equity. It's a routine, expected event, not indicating any immediate operational or financial distress or exceptional performance.

Positives

• The grant of restricted stock aligns the director's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• The compensation structure, vesting over approximately one year, encourages long-term commitment from the director.

Risks

• The value of the compensation is subject to market fluctuations of OHI's common stock until vesting.
• Future changes in company performance or market conditions could impact the ultimate value realized from the restricted stock grant.

Future Outlook

The restricted stock grant is set to vest on the date of Omega Healthcare Investors Inc.'s 2026 Annual Meeting of Shareholders, approximately one year from the grant date, converting to common stock on a one-for-one basis.

Management Comments

• The filing was signed by Meghan C. Lyons as Attorney-in-Fact for Burke W. Whitman, indicating the use of a pre-authorized power of attorney for SEC compliance.

Industry Context

This transaction is a routine director compensation event for a Real Estate Investment Trust (REIT) specializing in healthcare properties. Such equity grants are common practice across industries, including REITs, to align director incentives with long-term shareholder value.

Comparison to Industry Standards

• Equity compensation for directors, such as restricted stock grants, is a standard practice in corporate governance across publicly traded companies, including REITs like Omega Healthcare Investors Inc.
• The vesting period of approximately one year is typical for annual director compensation grants, similar to practices observed in other healthcare REITs such as Ventas, Inc. (VTR) or Welltower Inc. (WELL), which also utilize equity-based awards to incentivize their board members.

Corporate Governance

Related Party Transactions

• The acquisition of 4,388 shares by Director Burke W. Whitman as compensation from Omega Healthcare Investors Inc. constitutes a related party transaction, as it involves a transaction between the company and a member of its board of directors.

Stakeholder Impact

• Shareholders: The grant of restricted stock to a director aligns the director's financial interests with long-term shareholder value, as the compensation's value is tied to the company's stock performance.

Next Steps

• The restricted stock grant will vest on the date of the Company's 2026 Annual Meeting of Shareholders.

Key Dates

Keywords

Omega Healthcare Investors, OHI, Burke W. Whitman, Director Compensation, Restricted Stock Grant, Form 4, Insider Transaction, Healthcare REIT, Equity Compensation